Immunofluorescence Assay Market: Growing awareness about early disease detection
The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years. However, quality concerns over antibodies are the major challenge in this market. The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571 Reagents accounted for the larger share of the share of global immunofluorescence assays market in 2020 By product, the immunofluorescence assays market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories. The reagents segment accounted for for the largest share of global immunofluorescence assays market. Th...